A new report by the US Centers for Disease Control and Prevention (CDC) has shown that children with asthma are having fewer attacks and less visits to the hospital.

Titled ‘Vital Signs’, the report revealed that children who had one or more asthma attacks in the preceding 12 months decreased from 61.7% in 2001 to 53.7% in 2016.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

However, it was found that around 50% of children with asthma had one or more attacks in 2016.

CDC acting director Anne Schuchat said: “We are making progress – but healthcare providers, parents, caregivers, and schools can do more to help children avoid asthma attacks.

“We are making progress – but healthcare providers, parents, caregivers, and schools can do more to help children avoid asthma attacks.”

“Over the past decade, we’ve identified asthma management actions that work – not alone but in combination. Now we need to scale up these efforts nationwide.”

The report further showed that certain children such as boys, those aged five to 17 and those from low-income families are more likely to have asthma, while the attacks were found to be common in younger children during 2016.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Hospitalisations due to asthma were found to have decreased from 9.6% in 2003 to 4.7% in 2013, and the percentage of children missing school days because of the condition also dropped during this period.

CDC found that even though more children are receiving disease action plans, one out of six had to be taken to the emergency department and around one in 20 gets hospitalised each year.

The organisation believes that steps such as teaching children and parents about management of the condition could be highly effective in preventing asthma attacks.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact